Related Experiment Video
Updated: Jun 16, 2026
08:44
Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
Does body height reduction influence interpretation of lung function in COPD patients?
1Glittreklinikken, Pb 104 Aaneby, N-1485 Hakadal, Norway. aina.kjensli@glittreklinikken.no
The European Respiratory Journal
|January 30, 2010
Summary
Vertebral deformities in COPD patients cause height loss, potentially overestimating lung function. Using recalled tallest height or arm span height may improve accuracy for these patients.
Area of Science:
- Pulmonary Medicine
- Radiology
- Geriatrics
Background:
- Vertebral deformities are common in chronic obstructive pulmonary disease (COPD).
- Height reduction due to deformities can impact pulmonary function test (PFT) interpretation.
- Overestimation of lung function may occur if reduced height is used in PFT calculations.
Purpose of the Study:
- To determine the frequency of lung function misinterpretation due to height reduction in COPD patients.
- To investigate the correlation between vertebral deformities and height reduction.
- To assess the impact of height reduction on PFT results in COPD.
Main Methods:
- Cross-sectional study of 465 COPD patients and 462 controls.
- Height reduction assessed by comparing measured height to recalled tallest height (RTH) and arm span height (ASH).
- Vertebral deformities evaluated via radiographs; pulmonary function assessed using standard formulae.
Main Results:
- Height reduction was prevalent in both groups and increased with vertebral deformity number/severity.
- Significant lung function overestimation occurred in COPD patients with modest height reduction using current measured height.
- Effects on lung function varied, with total lung capacity and residual volume most affected.
Conclusions:
- Height reduction is common in COPD patients and linked to vertebral deformities.
- Current measured height can lead to overestimation of lung function in COPD.
- RTH or ASH may be better for PFT predictions in COPD patients with significant height loss; consider screening for osteoporosis.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: